Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Burning Rock Biotech's Cash from Operations rose 11451.81% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year increase of 7337.5%. This contributed to the annual value of -$12.6 million for FY2024, which is 6491.42% up from last year.
  • Burning Rock Biotech's Cash from Operations amounted to $2.3 million in Q3 2025, which was up 11451.81% from -$9.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Cash from Operations high stood at $2.6 million for Q4 2024, and its period low was -$66.2 million during Q4 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$15.9 million (2024), whereas its average is -$14.2 million.
  • Per our database at Business Quant, Burning Rock Biotech's Cash from Operations tumbled by 31304.9% in 2021 and then surged by 21573.58% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Cash from Operations (Quarter) stood at -$17.6 million in 2021, then tumbled by 275.71% to -$66.2 million in 2022, then soared by 96.59% to -$2.3 million in 2023, then skyrocketed by 215.74% to $2.6 million in 2024, then fell by 11.8% to $2.3 million in 2025.
  • Its Cash from Operations was $2.3 million in Q3 2025, compared to -$9.5 million in Q2 2025 and -$3.2 million in Q1 2025.